...
首页> 外文期刊>Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association >Highly-sensitive C-reactive protein, a biomarker of cardiovascular disease risk, in radically-treated differentiated thyroid carcinoma patients after repeated thyroid hormone withholding
【24h】

Highly-sensitive C-reactive protein, a biomarker of cardiovascular disease risk, in radically-treated differentiated thyroid carcinoma patients after repeated thyroid hormone withholding

机译:反复扣留甲状腺激素后,在自由基治疗的分化型甲状腺癌患者中,高敏感性C反应蛋白是心血管疾病风险的生物标志物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: In patients radically treated for differentiated thyroid carcinoma, we assessed the response of highly-sensitive C-reactive protein, an inflammatory biomarker for cardiovascular risk, after thyroid hormone withholding ("deprivationo"), as well as factors potentially influencing this response. Material and Methods: We included 52 adults (mean age 45.6±14.0 years, 35 females) who were disease-free after total thyroidectomy, radioiodine ablation and chronic thyroid hormone therapy. They were lifelong non-smokers without apparent inflammatory comorbidity, cardiovascular history beyond pharmacotherapy-controlled hypertension, anti-dyslipidemic medication, or C-reactive protein >10 mg/L in any study measurement. The index deprivation lasted ≥2 weeks, elevating serum thyrotropin >40 mIU/L or ≥100 × the individual's suppressed level. We examined the relationship of age, number of prior deprivations, and gender with the magnitude of post-deprivation C-reactive protein concentration through multivariable statistical analyses using the F test on linear regression models. Results: Post-deprivation, C-reactive protein reached intermediate cardiovascular risk levels (based on general population studies involving chronic elevation), 1-3 mg/L, in 44.2% of patients and high-risk levels, >3 mg/L, in another 17.3%. Mean C-reactive protein was 1.77±1.50 mg/L, differing significantly in females (2.12±1.66 mg/L) vs. males (1.05±0.69 mg/L, P <0.001). In multivariable analysis, patients ≤45 years old (odds ratio, 95% confidence interval 0.164 [0.049-0.548]) were less likely, and females, more likely (3.571 [1.062-12.009]) to have post-deprivation C-reactive protein ≥1 mg/L. Conclusions: Thyroid hormone withdrawal frequently elevated C-reactive protein to levels that when present chronically, were associated with increased cardiovascular risk in general population studies.
机译:目的:在对分化型甲状腺癌进行彻底治疗的患者中,我们评估了高敏感性C反应蛋白(一种抑制心血管疾病的炎症生物标志物)在甲状腺激素被扣留(“剥夺”)后的反应以及可能影响该反应的因素。材料和方法:我们纳入了52位成年人(平均年龄45.6±14.0岁,女性35位),这些患者在全甲状腺切除术,放射性碘消融术和慢性甲状腺激素治疗后均无病。他们是终生的非吸烟者,没有明显的炎症合并症,没有药物治疗控制的高血压的心血管病史,抗血脂异常药物,或任何研究指标中的C反应蛋白> 10 mg / L。指数剥夺持续≥2周,血清促甲状腺激素> 40 mIU / L或≥100×个人的抑制水平。我们使用线性回归模型上的F检验,通过多变量统计分析,考察了年龄,先前被剥夺的人数和性别与剥夺后C反应蛋白浓度大小之间的关系。结果:剥夺后,C反应蛋白达到中等心血管风险水平(基于涉及慢性升高的一般人群研究),为1-3 mg / L,占44.2%的患者,高风险水平,> 3 mg / L,在另外17.3%平均C反应蛋白为1.77±1.50 mg / L,女性(2.12±1.66 mg / L)与男性(1.05±0.69 mg / L)差异显着(P <0.001)。在多变量分析中,≤45岁(奇数比,95%置信区间0.164 [0.049-0.548])的患者患剥夺后C反应蛋白的可能性较小,而女性(3.571 [1.062-12.009])的可能性更大≥1mg / L。结论:甲状腺激素戒断常使C反应蛋白升高至长期存在时的水平,这与一般人群研究中心血管风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号